Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 100 shares at $987.33 ($98K) on 2024-03-01, disclosed to the SEC on 2024-03-05.
Scheduled sale ($98k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $967.50 | 1 | $968 | 1.0% |
| 2 | $968.66 | 1 | $969 | 1.0% |
| 3 | $969.18 | 1 | $969 | 1.0% |
| 4 | $970.38 | 4 | $4K | 4.0% |
| 5 | $971.75 | 1 | $972 | 1.0% |
| 6 | $972.29 | 2 |
| $2K |
| 2.0% |
| 7 | $974.78 | 1 | $975 | 1.0% |
| 8 | $975.70 | 2 | $2K | 2.0% |
| 9 | $976.81 | 2 | $2K | 2.0% |
| 10 | $977.27 | 2 | $2K | 2.0% |
| 11 | $978.09 | 1 | $978 | 1.0% |
| 12 | $979.87 | 1 | $980 | 1.0% |
| 13 | $980.21 | 1 | $980 | 1.0% |
| 14 | $981.64 | 15 | $15K | 15.0% |
| 15 | $982.67 | 11 | $11K | 11.0% |
| 16 | $983.61 | 12 | $12K | 12.0% |
| 17 | $984.45 | 19 | $19K | 19.0% |
| 18 | $985.76 | 10 | $10K | 10.0% |
| 19 | $986.58 | 8 | $8K | 8.0% |
| 20 | $987.33 | 4 | $4K | 4.0% |
| 21 | $988.30 | 1 | $988 | 1.0% |
| Total | $982.05 avg | 100 | $98K | 100% |
| Filing → |
| REGN | SELL | 2026-04-03 | $78K | — | Filing → |
| REGN | SELL | 2026-03-03 | $79K | — | Filing → |
| REGN | SELL | 2026-02-11 | $78K | — | Filing → |